Hans M. Smit

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Best supportive care in stage I-III non-small cell lung cancer: survival by reason for curative treatment omission in a real-world study population.

Best supportive care in stage I-III non-small cell lung cancer: survival by reason for curative treatment omission in a real-world study population.

Journal: Translational lung cancer research

Published: March 19, 2026

Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy.

Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy.

Journal: Clinical and translational radiation oncology

Published: October 21, 2025

Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI Categories.

Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI Categories.

Journal: Therapeutic drug monitoring

Published: November 22, 2024

Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer.

Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer.

Journal: Translational lung cancer research

Published: November 21, 2024

Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer.

Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer.

Journal: Frontiers in digital health

Published: September 28, 2023

Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer.

Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer.

Journal: Journal for immunotherapy of cancer

Published: October 12, 2022

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 10, 2022

Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice.

Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice.

Journal: BMC pulmonary medicine

Published: March 28, 2022

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.

Journal: Therapeutic advances in medical oncology

Published: March 05, 2022

An invisible group of COVID-19 victims; impact on Dutch lung cancer care.

An invisible group of COVID-19 victims; impact on Dutch lung cancer care.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 17, 2021

Efficacy of an Autologous Blood Patch for Prolonged Air Leak: A Systematic Review.

Efficacy of an Autologous Blood Patch for Prolonged Air Leak: A Systematic Review.

Journal: The Annals of thoracic surgery

Published: December 18, 2020

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer.

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer.

Journal: Journal for immunotherapy of cancer

Published: December 11, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026